PRESS RELEASE published on 05/10/2023 at 10:15, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/10/2023 at 10:15, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/09/2023 at 10:40, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/09/2023 at 10:40, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/09/2023 at 09:18, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/09/2023 at 09:18, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/05/2023 at 10:41, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
PRESS RELEASE published on 05/05/2023 at 10:41, 2 years 1 month ago Amundi MSCI Emerging Markets UCITS ETF - USD (C): Net Asset Value(s)
Published on 06/18/2025 at 15:15, 31 minutes ago Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging
Published on 06/18/2025 at 15:00, 46 minutes ago iAccess Alpha's Virtual Best Ideas Summer Investment Conference June 24-25, 2025
Published on 06/18/2025 at 14:50, 56 minutes ago Rio Grande Resources Announces Positive Assay Results From its Sampling and Field Campaign at the Winston Gold-Silver Project, New Mexico USA
Published on 06/18/2025 at 14:30, 1 hour 16 minutes ago Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones
Published on 06/18/2025 at 14:30, 1 hour 16 minutes ago MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
Published on 06/18/2025 at 15:30, 16 minutes ago Hong Kong Baptist University and Elsevier Report Highlights Global Expansion of Chinese Medicine Research, Urges Standardised Frameworks for Broader Integration
Published on 06/18/2025 at 15:29, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 06/18/2025 at 15:28, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 06/18/2025 at 15:27, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
Published on 06/18/2025 at 14:21, 1 hour 25 minutes ago Definitieve resultaten van de kapitaalverhoging
Published on 06/18/2025 at 09:39, 6 hours 7 minutes ago Eerste fase van het openbaar aanbod in het kader van een kapitaalverhoging is succesvol afgerond waarbij reeds werd ingeschreven op ongeveer 75,56% van de Nieuwe Aandelen Lancering van een versnelde private plaatsing van Scrips
Published on 06/18/2025 at 09:39, 6 hours 7 minutes ago First phase of the public offering in the framework of the capital increase has been successfully completed with about 75.56% of the New Shares already subscribed Launch of an accelerated private placement of Scrips
